BIOTE CORP -A (BTMD)
US0906831039 - Common Stock
Which stocks are moving after the closing bell on Wednesday?
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
BTMD Stock Earnings: Biote Misses EPS, Beats Revenue for Q1 2024
BTMD stock results show that Biote missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
BTMD Stock Earnings: Biote Misses EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biote (NASDAQ:BTMD) just reported results for the first quarter of 2024.Biote r...
Biote Reports First Quarter 2024 Financial Results
Biote Announces Definitive Settlement with Founder
Biote Schedules First Quarter 2024 Financial Results Release and Conference Call
Biote Reports Fourth Quarter and Full Year 2023 Financial Results
Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call
Biote announces agreement to resolve litigation with founder Gary Donovitz (NASDAQ:BTMD)
Biote (BTMD) plans to repurchase all shares owned by founder Gary Donovitz, resolving outstanding litigation and investing $76.9M over three years.
Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder’s Shares
Biote announces $20M share repurchase authorization (NASDAQ:BTMD)
Biote (BTMD) approves a $20 million share repurchase program, marking its first authorization for buybacks.
Biote Announces $20 Million Share Repurchase Authorization
Biote expects 2023 revenue to be below provided outlook (NASDAQ:BTMD)
Biote Corp revises its 2023 revenue and EBITDA guidance slightly lower. Q4 2023 expected revenue and EBITDA also provided.
Biote to buy Asteria Health for $8.5M (NASDAQ:BTMD)
Biote Corp revises its 2023 revenue and EBITDA guidance slightly lower. Q4 2023 expected revenue and EBITDA also provided.
Biote to Purchase Asteria Health
Biote Provides Preliminary 2023 Results and Initial 2024 Guidance
Biote names Robert Peterson as its CFO (NASDAQ:BTMD)
Biote announces the appointment of Robert Peterson as its CFO, effective January 8, 2024.
Biote Names Robert Peterson as Chief Financial Officer
Biote Reports Third Quarter 2023 Financial Results
Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call
Biote Reports Second Quarter 2023 Financial Results
Biote Schedules Second Quarter 2023 Financial Results Release and Conference Call
Biote Formalizes Commitment to Men’s Hormone Health With Launch of New Men’s Health Division
Biote down 7% on pricing secondary offering (NASDAQ:BTMD)
Personalised hormone therapy provider, biote (BTMD) prices an underwritten offering of 5,217,392 shares at a price of $5.35 per share.Underwriters have a 30-day option to purchase...
Biote Announces Pricing of Secondary Offering of Common Stock
Biote to Participate at Upcoming Investor Conferences
Biote Appoints Mary J. Puncochar as Chief Commercial Officer
Biote reports Q1 results, maintains FY 2023 revenue guidance (NASDAQ:BTMD)
Biote press release (BTMD): Q1 GAAP EPS of -$0.39.Revenue of $44.8M (+20.8% Y/Y).Maintains FY 2023 revenue guidance of $190M-$200M vs
Biote Reports First Quarter 2023 Financial Results